Sign in
CompletedNo phase

Sugammadex and Neostigmine in Pediatric Patients

Key facts

Who runs it
Marmara University
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
130 people enrolled
Started
8 Nov 2022
Ended
15 Apr 2024
Type of study
Observational, 2 groups
Treatments tested
  • Group N; neostigmine+atropine
  • GROUP S; decurarized with sugammadex.
Record updated
29 May 2024

Who can take part

Age
5 years to 12 years
Sex
Women and men

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • After the approval of the local ethics committee and written consent from the family ASA 1 5-12 years old

Who cannot take part

  • history of allergy or anaphylaxis to one of the drugs used children with autism children with auditory problems family without consent

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

In this study, it was aimed to compare the use of sugammadex instead of neostigmine + atropine in the reversal of NMB in children undergoing lower abdominal surgery or urogenital surgery, and to compare the rates of postoperative agitation, nausea and vomiting using the FLACC scale, PAED scale and ICC parameters.After the approval of the local ethics committee and written consent from the family, patients who underwent ASA 1, 5-12 years old lower abdomen surgery or urogenital surgery in Pendik Training and Research Hospital will be included in the study.

Read full original descriptionShow less

The patients included in the study will be those who were maintained with routine 2-3% sevoflurane inhalation anesthetic and 0.2mcg/kg/min remifentanil intravenous anesthetic, and decurarized with 0.5-1 mg/kg rocuronium. No drugs other than those administered by the responsible Anesthesiologist during the operation will be administered.

The patients included in the study will be divided into 2 groups according to the agent used in decurarization. There is no condition for the number of patients in the group to be equal. Group N; neostigmine+atropine, GROUP S; This will be the group of patients decurarized with sugammadex.

0-45 days after patients are extubated. And at the 2nd hour, FLACC Scale (Pain Diagnostic Scale), PAED (Pediatric Anesthesia Recovery Delirium) Scale assessment methods will be compared in terms of pain and agitation. Nausea and vomiting will be noted as yes/no.

The 2 groups in the trial

  • neostigmin+atropin

    This will be the group of patients decurarized with neostigmine+atropine,

    Treatment: Group N; neostigmine+atropine

  • sugammadeks

    This will be the group of patients decurarized with sugammadex.

    Treatment: GROUP S; decurarized with sugammadex.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Comparison of Sugammadex and Neostigmine in Terms of Awakening, Pain, Agitation, Nausea and Vomiting in Pediatric Patients''
Record updated
29 May 2024